Point/Counterpoint: A Disruptive Innovation or a Costly Disruption?

A First in Intraoperative Drug Delivery for Cataract Surgery BY ERIC DONNENFELD, MD, AND ALLISON W. SHUREN, JD The future of pharmaceuticals and cataract surgery is unequivocally drug delivery. Omidria (phenylephrine and ke...

Full Story →